Abstract
Clinicians involved in the treatment of children with tumors require diagnostic imaging methods for staging, monitoring effects of treatment, determining optimum timing for definitive surgical procedures or other changes in treatment, and early detection of recurrence. Traditionally, gallium-67 (67Ga) has been the mainstay of pediatric tumor scintigraphy. Thallium-201 (201Tl) and more recently technetium-99m (99mTc)-sestamibi are being used for imaging a wide variety of pediatric primary and metastatic tumors of bone, soft tissue, head and neck, and lymphoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdel-Dayem HM, Sanchez J, Al-Mohannadi S, Kempf J. Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med 1992;33:2014–2016
Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: preliminary results and comparison withTl-201. Clin NuclMed 1992;17:171–176
Aktolun C, Demirel D, Kir M, Bayhan H, Maden HA. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J Nucl Med 1991;32:1429–1431
Anderson KC, Leonard RCF, Canellos GP, Skarin AT, Kaplan WD. High dose gallium imaging in lymphoma. Am J Med 1983;75:327–331
Ando A, Ando I, Katayama M, et al. Biodistributions of 201-thallium in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987;12:567–572
Ando A, Ando I, Sanada S, Hiraki T, Hisada K. Tumor and liver uptake models of 67Ga-citrate. Eur J Nucl Med 1985;10:262–268
Ando A, Ando I, Sanada S, et al. Study of the distribution of tumor affinity metal compounds and alkaline metal compounds in the tumor tissues by microautoradiography. Int J Nucl Med Biol 1984;11:195–201
Atkins HL, Budinger TF, Lebowitz E, et al. Thallium-201 for medical use. Part 3. Human distribution and physical imaging properties. J Nucl Med 1977;18:133–140
Balon HR, Fink-Bennett D, Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid. J Nucl Med 1992; 33:1393–1395
Bearcroft PWP, Wraight EP. Visualization of the axillary vein during 99m-Tc methoxy-isobutyl-isonitrile (MIBI) myocardial imaging. Br J Radiol 1992;65:947–948
Bekerman C, Pavel DG, Bitran J, Ryo UY, Pinsky S. The effects of inadvertent administration of antineoplastic agents prior to Ga-67 injection: concise communication. J Nucl Med 1984;25:430–435
Bekerman C, Port RB, Pang E, Moohr JW, Kranzler JK. Scintigraphic evaluation of childhood malignancies by 67Ga-citrate. Radiology 1978; 127: 719–725
Bergström M. Positron emission tomography in tumor diagnosis and treatment follow-up. Acta Oncol 1993;32:183–188
Berquist T. Magnetic resonance imaging of primary skeletal neoplasms. Radiol Clin North Am 1993; 31:411–424
Biersack HJ, Briele B, Hotze AL, et al. The role of nuclear medicine in oncology. Ann Nucl Med 1992;6:131–136
Bitran JD, Bekerman C, Golomb HM, Simon MA. Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate. Cancer 1978;42: 1760–1765
Black KL, Hawkins RA, Kim KT et al. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342–346
Bradley-Moore PR, Lebowitz E, Greene MW, Atkins HL, Ansari AN. Thallium-201 for medical use. II. Biologic behavior. J Nucl Med 1975; 16: 156–160
Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 1989;500:30–36
Britten JS, Blank M. Thallium activation of the (Na+-K+)-activated ATPase of rabbit kidney. BiochimBiophys Acta 1968;159:160–166
Burke GJ, Wei JP, Binet EF. Parathyroid scintigraphy with iodine-123 and Tc-99m sestamibi: imaging findings. AJR 1993;161:1265–1268
Caluser C, Macapinlac H, Healey J, et al. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin Nucl Med 1992:17:565–572
Campeau RJ, Kronemer KA, Sutherland CM. Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor. Clin Nucl Med 1992;17:936–937
Caner B, Kitapçi M, Aras T, et al. Increased accumulation of hexakis (2-methoxyisobutylisonitrile)tech-netium(I) in osteosarcoma and its metastatic lymph nodes. J Nucl Med 1991;32:1977–1978
Caner B, Kitapçi M, Unlü M, et al. Technetium-99m MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99-MDP. J Nucl Med 1992;33:319–324
Carvalho PA, Schwartz RB, Alexander E, et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992;77:565–570
Cavailloles F, Vitaux F, Petiet A, Vitaux J. Thallium uptake in fasted and nonfasted rats. Eur J Nucl Med 1983;8:87–88
Charkes ND, Vitti RA, Brooks K. Thallium-201 SPECT increases detectability of thyroid cancer metastases. J Nucl Med 1990;31:147–153
Chen DCP, Ma GQ, Ansari A, et al. Optimal imaging time for thallium as a tumor agent in patients with lymphoma [abstract]. J Nucl Med 1992;33:844
Chen LB. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988;4:155–181
Chiu ML, Herman LW, Kronauge JF, Piwnica-Worms D. Comparative effects of neutral dipolar compounds and lipophilic anions on technetium 99m-hexakis (2-methoxyisobutyl isonitrile) accumulation in cultured chick ventricular myocytes. Invest Radiol 1992;27:1052–1058
Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646–1653
Cogswell A, Howman-Giles R, Bergin M. Bone and gallium scintigraphy in children with rhabdomyosarcoma: a 10-year review. Med Pediatr Oncol 1994;22:15–21
Cohen M, Hill CA, Cangir A, Sullivan M. Thymic rebound after treatment of childhood tumors. AJR 1980;135:151–156
Cox PH, Belfer AJ, van der Pompe WB. Thallium 201 chloride uptake in tumours, a possible complication in heart scintigraphy. Br J Radiol 1976;49:767–768
Crane P, Laliberté R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993;20:20–25
Culver CM, Dworkin HJ. Comparison of personnel radiation dosimetry from myocardial perfusion scintigraphy: technetium-99m-sestamibi versus thallium-201. J Nucl Med 1993;34:1210–1213
Darcourt J, Chang L, McBride D, et al. Comparison of Tl-201 and Tc-99m-sestamibi SPECT for brain tumor detection [abstract]. Clin Nucl Med 1993; 18:925
Davidson RM, Round ME, Lamki N, et al. Tl-201 chloride scan in multiple endocrine neoplasia type 2A. Clin Nucl Med 1992;17:406–408
Desai SP, Yuille DL. Visualization of a recurrent carcinoid tumor and an occult distant metastasis by technetium-99m-sestamibi. J Nucl Med 1993;34: 1748–1751
DeVito RP, Hamill JJ. Determination of weighting functions for energy-weighted acquisition. J Nucl Med 1991;32:343–349
DeVito RP, Hamill JJ, Treffert JD, Stoub EW. Energy-weighted acquisition of scintigraphic images using finite spatial filters. J Nucl Med 1989;30:2029–2035
Donahue DM, Leonard JC, Basmadjian GP, et al. Thymic gallium-67 localization in pediatric patients on chemotherapy: concise communication. J Nucl Med 1981;22:1043–1048
Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS. Pediatric Hodgkin’s disease (II): results of therapy. Cancer 1976;37:2436–2447
Edeling CJ. Ga-67 imaging in pediatric oncology. Clin Nucl Med 1983;8:205–209
Elgazzar AH, Fernandez-Ulloa M, Silberstein EB. 201T1 as a tumour-localizing agent: current status and future considerations. Nucl Med Commun 1993;14:96–103
Elgazzar AH, Malki AA, Abdel-Dayem HM, et al. Role of thallium-201 in the diagnosis of solitary bone lesions. Nucl Med Commun 1989; 10:477–485
Floyd JL, Mann RB, Shaw A. Changes in quantitative SPECT thallium-201 results associated with the use of energy-weighted acquisition. J Nucl Med 1991;32:805–807
Földes I, Lévay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechne-tate and technetium-99m methoxyisobutylisoni-trile. Eur J Nucl Med 1993;20:330–333
Gal R, Port SC. Arm vein uptake of thallium-201 during exercise: incidence and clinical significance. J Nucl Med 1986;27:1353–1357
Ganz WI, Nguyen TQ, Mnaymneh W, et al. Use of early, late and SPECT thallium imaging in evaluating activity of soft tissue and bone tumors [abstract]. J Nucl Med l993;34:33
Gehring PJ, Hammond PB. The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther 1967;155:187–201
Gelfand MJ. Meta-iodobenzylguanidine in children. Semin Nucl Med 1993;23:231–242
Gilday DL, Ash JM, Reilly BJ. Radionuclide skeletal survey for pediatric neoplasms. Radiology 1977;123:399–406
Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology 1993;7:41–46
Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma: the Memorial Hospital experience. Cancer 1992;69:698–708
Glover DK, Okada RD. Myocardial technetium 99m sestamibi kinetics after reperfusion in a canine model. Am Heart J 1993;125:657–666
Graham MM, Eary JF, Winder DP, et al. Sestamibi imaging of sarcoma response to therapy [abstract]. Clin Nucl Med 1993;18:929
Hammersley PAG, Zivanovic MA. Gallium-67 uptake in the regenerating rat liver. J Nucl Med 1976;17:226
Hardoff R, Baron E, Sheinfeld M. Early and late lesion-to-non-lesion ratio of thallium-201 chloride uptake in the evaluation of “cold” thyroid nodules. J Nucl Med 1991;32:1873–1876
Harris EW, Rakow JI, Weiner M, Agress H Jr. Thallium-201 scintigraphy for assessment of a gal-lium-67-avid mediastinal mass following therapy for Hodgkin’s disease. J Nucl Med 1993; 34:1326–1330
Hartman RE, Hayes RL. The binding of gallium by blood serum. J Pharmacol Exp Ther 1969; 168: 193–198
Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989; 14:333–340
Hawkins RA, Hoh C, Glaspy J, et al. The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 1992;22:268–284
Hibi S, Todo S, Imashuku S. Thymic localization of gallium-67 in pediatric patients with lymphoid and nonlymphoid tumours. J Nucl Med 1987;28: 293–297
Hisada K, Tonami N, Miyamae T, et al. Clinical evaluation of tumor imaging with 201-T1 chloride. Radiology 1978;129:497–500
Hoffer PB. Mechanisms of localization. In Hoffer PB, Bekerman C, Henkin RE (eds): Gallium-67 Imaging. New York: Wiley, 1978
Hoffer PB, Schor R, Ashby D, et al. Comparison of Ga-67 citrate images obtained with rectilinear scanner and large-field Anger camera. J Nucl Med 1977;18:538–541
Hoffman JM, Hanson MW, Coleman RE. Clinical positron emission tomography imaging. Radiol Clin NorthAm 1993;31:935–959
Holman BL, Zimmerman RE, Johnson KA, et al. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain. J Nucl Med 1991;32:1478–1484
Howman-Giles R, Stevens M, Bergin M. Role of gallium-67 in management of paediatric solid tumors. AustPaediatri J 1982;18:120–125
Howman-Giles R, Uren R, White G, Shaw P. Tl-201 scintigraphy in paediatric solid tumors [abstract]. J Nucl Med 1993;34:52
Iosilevsky G, Front D, Bettman L, Hardoff R, Ben-Arieh Y. Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 1985;26:278–282
Iosilevsky G, Israel O, Frenkel A, et al. A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose. Semin Nucl Med 1989;19:33–46
Israel O, Front D. Benign mediastinal and parahilar uptake of gallium-67 in treated lymphoma: do we have all the answers? J Nucl Med 1993; 34:1330–1332
Ito Y, Muranaka A, Harada T, et al. Experimental study on tumor affinity of 201T1 chloride. Eur J Nucl Med 1978;3:81–86
Kao CH, Wang SJ, Lin WY, et al. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993; 20:249–254
Kaplan WD. Residual mass and negative gallium scintigraphy in treated lymphoma: when is the gallium scan really negative? J Nucl Med 1990; 31:369–371
Kaplan WD, Southee AE, Annese ML, Jochhelson MS, Nadler LM. Evaluating low and intermediate grade non-Hodgkin’s lymphoma with gallium-67 (Ga) and thallium-201 (Tl) imaging [abstract]. J Nucl Med 1990;31:793
Kaplan WD, Takvorian T, Morris JH, et al. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28:47–52
Kaufman JH, Cedermark BJ, Parthasarathy KL, Didolkar MS, Bakshi SP. The value of Ga-67 scintigraphy in soft-tissue sarcoma and chondrosarcoma. Radiology 1977;123:131–134
Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965–969
Kobayashi H, Sakahara H, Hosono M, et al. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercapto-succinic acid scintigraphy. Radiology 1994; 190:277–280
Kohno H, Iizuka Y, Suzuki T, Ohkubo Y, Kubodera A. Developmental changes in tissue distribution of gallium-67 citrate. J Nucl Med 1985;26:761–764
Kosuda S, Aoki S, Suzuki K, Nakamura O, Shidara N. Reevaluation of quantitative thallium-201 brain SPECT for brain tumor [abstract]. J Nucl Med 1992;33:844
Kowalsky RJ, Perry JR. Radiopharmaceuticals in Nuclear Medicine Practice. Norwalk, CT: Appleton & Lange, 1987
Krasnow AZ, Collier BD, Isitman AT, Hellman RS, Peck DC. The clinical significance of unusual sites of thallium-201 uptake. Semin Nucl Med 1988;18:350–358
Krishna L, Slizofski WJ, Katsetos CD, et al. Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 1992; 33:2017–2019
Laliberté F, Barry T, Gagnon S, Lambert R. Tumor imaging with Tl-201 or Tc-99m MIBI in children: patient preparation and technical aspects [abstract]. J Nucl Med Technol 1993;21:117
Lawrence JA, Babyn PS, Chan HS, et al. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging. Radiology 1993; 189:43–47
Lebouthillier G, Morais J, Picard M, et al. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Clin Nucl Med 1993;18:657–661
Lebowitz E, Greene MW, Fairchild R, et al. Thallium-201 for medical use. I. J Nucl Med 1975;16:151–155
Lee VW. Unsuspected malignant pheochromocy-toma: appearance on thallium and gallium scans. AJR1993;161:1333
Lee VW, Chen H, Panageas E, O’Keane JC, Liebman HA. Subcutaneous Kaposi’s sarcoma: thallium scan demonstration. Clin Nucl Med 1990;15:569–571
Lee VW, Fuller JD, O’Brien MJ, et al. Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 1991; 180:409–412
Lee VW, Sax EJ, McAneny DB, et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993;34:2095–2100
Luker GD, Siegel MJ. Mediastinal Hodgkin disease in children: response to therapy. Radiology 1993; 189:737–740
Macapinlac H, Scott A, Caluser C, et al. Comparison of Tl-201 and Tc-99m-2-methoxy isobutyl isonitrile (MIBI) with MRI in the evaluation of recurrent brain tumors [abstract]. J Nucl Med 1992;33:867
Magid D. Two-dimensional and three-dimensional computed tomographic imaging in musculoskeletal tumors. Radiol Clin North Am 1993;31:425–447
Majd M, Packer R, Vezina G, Melis K, Chadduck W Thallium-201 brain SPECT in childhood brain tumors [abstract]. J Nucl Med 1993;34:52
Maublant JC, Zhang Z, Rapp M, et al. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993;34:1949–1952
McLaughlin AF, Magee MA, Greenough R, et al. Current role of gallium scanning in the management of lymphoma. Eur J Nucl Med 1990;16:755–771
Mountz JM, Raymond PA, McKeever PE, et al. Specific localization of thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989;49:4053–4056
Mountz JM, Rosenfeld SS, Li Y. Utility of Tl-201 and Tc-99m sestamibi SPECT for early determination of malignant brain tumor chemotherapy efficacy [abstract]. J Nucl Med 1993;34:206
Mousa SA, Cooney JM, Stevens S. Kinetics of technetium-99m-sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the ‘redistribution’ phenomenon. Cardiology 1992;81:157–163
Mousa SA, Williams S J, Sands H. Characterization of in vivo chemistry of cations in the heart. J Nucl Med 1987;28:1351–1357
Muranaka A. Accumulation of radioisotopes with tumor affinity. II. Comparison of the tumor accumulation of Ga-67 citrate and thallium-201 chloride in vitro. Acta Med Okayama 1981;35:85–101
Mut F, Bianco A, Nunez M, De Palma G, Touya E. Tc-99m isonitrile uptake in a brain metastatic lesion: comparison with Tc-99m DTPA using planar and SPECT imaging. Clin Nucl Med 1993;18: 143–146
Nadel HR. Thallium-201 for oncological imaging in children. Semin Nucl Med 1993;23:243–254
Nadel HR, Frankel M, Chan KW, Stringer DA. Evaluation of Tl-201 scintigraphy in pediatric extremity osteogenic sarcoma [abstract]. Radiology 1992;185:107
Nadel HR, Poskitt KJ, Flodmark CO. Thallium beyond the heart: a pediatric experience [abstract]. Radiology 1989;173:151
Nadel HR, Poskitt KJ, Flodmark CO. Thallium scintigraphy in childhood neoplasms [abstract]. J Nucl Med 1990;31:939
Nakano S, Hasegawa Y, Kuriyama K, Kajita A, Ishigami S. Visualization of jugular vein on a thallium-201 scan for thyroid cancer. Clin Nucl Med 1989;14:449–450
Nishizawa K, Okunieff P, Elmaleh D, et al. Blood flow of human soft tissue sarcomas measured by thallium-201 scanning: prediction of tumor response to radiation. Int J Radiat Oncol Biol Phys 1991;20:593–597
O’Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. JNuclMed 1992;33:313–318
Ogawa T, Kanno I, Hatazawa J, et al. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 1994; 14:101–110
Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34:2085–2089
Osmanagaoglu K, Schelstraete K, Lippens M, Obrie E, De Feyter I. Visualization of a parathyroid adenoma with Tc-99m MIBI in a case with iodine saturation and impaired thallium uptake. Clin Nucl Med 1993;18:214–216
O’Tuama LA, Janicek MJ, Barnes PD, et al. 201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors. Pediatr Neurol 1991; 7:249–257
O’Tuama LA, Packard AB, Treves ST. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J Nucl Med 1990;31:2040–2041
O’Tuama LA, Treves ST, Larar JN, et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993;34:1045–1051
Parker JA. Quantitative SPECT: basic theoretical considerations. Semin Nucl Med 1989;19:3–12
Picci P, Rougraff BT, Bacci G, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastic Ewing’s sarcoma of the extremities. J Clin Oncol 1993;11:1763–1769
Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistant P-glyco-protein with an organotechnetium complex. Cancer Res 1993;53:977–984
Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J Nucl Med 1990;31:1166–1167
Piwnica-Worms D, Kronauge JF, Chiu ML. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells. J Nucl Med 1991; 32:1992–1999
Podoloff DA, Kim EE, Haynie TP. SPECT in the evaluation of cancer patients: not quo vadis; rather, ibi fere summus. Radiology 1992;183:305–317
Pruim J, Nieweg OE, Paans AMJ, et al. Efficacy assessment of regional chemotherapy of soft tissue sarcomas by FDG-PET [abstract]. J Nucl Med 1993:34:225
Ramanna L, Waxman A, Binney G, et al. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31:567–572
Ramanna L, Waxman AD, Rosen G. Evaluation of Tl-201 (Tl) uptake pattern in bone lesions: differentiation of benign from malignant processes [abstract]. J Nucl Med 1992;33:869
Ramanna L, Waxman AD, Weiss A, Rosen G. Thallium-201 (Tl-201) scan patterns in bone and soft tissue sarcoma [abstract]. J Nucl Med 1992; 33:843
Rao MG, Bone imaging with energy-weighted acquisition. J Nucl Med 1993;34:997–999
Rosen G, Loren GJ, Brien EW, et al. Serial thallium-201 scintigraphy in osteosarcoma: correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop 1993;293:302–306
Rossleigh MA, Murray IPC, Mackey DWJ, Bargwanna KA, Nayanar VV. Pediatric solid tumors: evaluation by gallium-67 SPECT studies. J Nucl Med 1990;31:168–172
Rubertone JA, Woo DV, Emrich JG, Brady LW Brain uptake of thallium-201 from the cerebrospinal fluid compartment. J Nucl Med 1993;34:99–103
Salvatore M, Carratù L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology 1976;121:487–488
Schwartz RB, Carvalho PA, Alexander E, et al. Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201T1 and 99mTc -HMPAO. AJNR 1991;12: 1187–1192
Scott AM, Kostakoglu L, O’Brien JP, et al. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 1992;33:1396–1398
Scott AM, Larson SM. Tumor imaging and therapy. Radiol Clin North Am 1993;31:859–879
Sehweil A, McKillop JH, Ziada G, et al. The optimum time for tumour imaging with thallium-201. Eur J Nucl Med 1988;13:527–529
Sehweil AM, McKillop JH, Milroy R, et al. Mechanism of 201T1 uptake in tumours. Eur J Nucl Med 1989;15:376–379
Sessler MJ, Geck P, Maul FD, Hör G, Munz DL. New aspects of cellular thallium uptake: Tl+-Na+-2C1- cotransport is the central mechanism of ion uptake. Nucl Med 1986;23:24–27
Shih WJ, Kadzielawa K, Lee C, Moody EB, Ryo UY. Tc-99m sestamibi uptake by cerebellar metastasis from bronchogenic carcinoma. Clin Nucl Med 1993;18:887–890
Simon MA, Kirchner PT. Scintigraphic evaluation of primary bone tumors: comparison of technetium-99m phosphonate and gallium citrate imaging. J Bone Joint Surg [Am] 1980;62:758–764
Sostman HD, Prescott DM, Dewhirst MW, et al. MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. Radiology 1994; 190: 269–275
Southee AE, Kaplan WD, Jochelson MS, et al. Gallium imaging in metastatic and recurrent soft-tissue sarcoma. J Nucl Med 1992;33:1594–1599
Stobbe DE, Berman S, Sanford I, Milne N, Lyons KP. Localization of Kaposi’s sarcoma by Tc-99m sestamibi compared to Tl-201: a pilot study [abstract]. Clin Nucl Med 1993; 18:925
Stull MA, Kransdorf MJ, Devaney KO. Langerhans cell histiocytosis of bone. Radiographics 1992; 12:801–823
Sty JR, Kun LE, Starshak RJ. Pediatric applications in nuclear oncology. Semin Nucl Med 1985; 15: 171–200
Suga K, Fujita T, Nakada T, et al. Preliminary Tl-201 SPECT for assessment of treatment efficacy in three patients with pancreatic cancer. Clin Nucl Med 1993;18:771–775
Suga K, Sadanaga Y, Nishigauchi K, Uschisako H, Nakanishi T. Lobar primary pulmonary lymphoma: iodine-123-iodoamphetamine and thallium-201 -chloride scintigraphic findings. J Nucl Med 1993; 34:1980–1983
Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801–1807
Takechi T, Mochizuki T, Murase K, et al. Dual energy acquisition for liver tumor imaging by thal-lium-201 and technetium-99m phytate with high resolution three head SPECT [abstract]. J Nucl Med 1992;33:976
Takeda S, Uchida T, Matsuzawa T. A comparative study on lysosomal accumulation of gallium-67 and indium-111 in Morris hepatoma 7316A. J Nucl Med 1977;18:835–839
Tanasescu DE, Hurvitz C, Waxman AD, Ramanna L, Rosen G. Thallium scintigraphy in pediatric oncology [abstract]. Radiology 1989;173:182
Thrall J, Freitas J, Gross M, et al. Non-cardiac organ perfusion imaging with thallium-201 [abstract]. J Nucl Med 1978;19:708–709
Togawa T, Yui N, Kinoshita F, et al. Diagnosis of pancreatic cancer using 201Tl-chloride and a three-head rotating gamma camera SPECT system. Kaku Igaku [Japanese Journal of Nuclear Medicine] 1991;28:1475–1481
Tonami N. Thallium-201 SPECT in the evaluation of gliomas. J Nucl Med 1993;34:2089–2090
Tonami N, Hisada K. Clinical experience of tumor imaging with thallium-201 chloride. Clin Nucl Med 1977;2:75–81
Tonami N, Matsuda H, Ooba H, et al. Thallium-201 accumulation in cerebral candidiasis: unexpected finding on SPECT. Clin Nucl Med 1990;15: 397–400
Tonami N, Shuke N, Yokoyama K, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997–1004
Tsan MF, Scheffel U. Mechanism of gallium-67 accumulation in tumors. J Nucl Med 1986; 27:1215–1219
Tumeh SS, Rosenthal DS, Kaplan WD, English RJ, Holman BL. Lymphoma: evaluation with Ga-67 SPECT. Radiology 1987;164:111–114
Turner DA, Pinsky SM, Gottschalk A, et al. The use of 67-Ga scanning in the staging of Hodgkin’s disease. Radiology 1972;104:97–101
Vallabhajosula SR, Harwig JF, Siemsen JK, Wolf W. Radiogallium localization in tumors: blood binding and transport and the role of transferrin. J Nucl Med 1980;21:650–656
Van Der Wall H, Murray IPC, Huckstep RL, Philips RL. The role of thallium scintigraphy in excluding malignancy in bone. Clin Nucl Med 1993;18: 551–557
Vanarthos WJ, Ganz WI, Vanarthos JC, Serafini AN, Tehranzadeh J. Diagnostic uses of nuclear medicine in AIDS. Radiographics 1992;12:731–749
Wackers FJT, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isoni-trile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30:301–311
Waxman A, Ashok G, Kooba A, et al. The use of Tc-99m-methoxy isobutyl isonitrile (MIBI) in evaluation of patients with primary carcinoma of the breast: comparison with Tl-201 (Tl) [abstract]. J Nucl Med 1993;34:139
Waxman AD. Thallium in nuclear oncology. In: Freeman LM (ed): Nuclear Medicine Annual. New York: Raven Press, 1991
Waxman AD, Ashok G, Khan S, et al. The use of methoxy isobutyl isonitrile (MIBI) in evaluation of patients with primary carcinoma of the breast [abstract]. Clin Nucl Med 1993;18:925
Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993; 34:18–23
Waxman AD, Ramanna L, Said J. Thallium scintigraphy in lymphoma: relationship to gallium-67 [abstract]. J Nucl Med 1989;30:915
Wei JP, Burke GJ, Mansberger AR Jr. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 1992; 112:1111–1117
Winchell HS. Mechanisms for localization of radiopharmaceuticals in neoplasms. Semin Nucl Med 1976;6:371–378
Yang SL, Alderson PO, Kaizer HA, Wagner HN Jr. Serial Ga-67 citrate imaging in children with neoplastic disease: concise communication. J Nucl Med 1979;20:210–214
Yeh SDJ, Rosen G, Caparros B, Benua RS. Semiquantitative gallium scintigraphy in patients with osteogenic sarcoma. Clin Nucl Med 1984; 9:175–183
Zhang JJ, Park CH, Kim SM, Ayyangar KM, Haghbin M. Dual isotope SPECT in the evaluation of recurrent brain tumor. Clin Nucl Med 1992; 17:663–664
Zolty IS, Murthy S, Delaney ML, Machac J. Technical considerations of thallium-201 whole body scanning [abstract]. J Nucl Med Technol 1993;21:112
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nadel, H.R., Rossleigh, M.A. (1995). Tumor Imaging. In: Treves, S.T. (eds) Pediatric Nuclear Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4205-3_23
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4205-3_23
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-4207-7
Online ISBN: 978-1-4757-4205-3
eBook Packages: Springer Book Archive